Description: Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Home Page: www.sequanamedical.com
Kortrijksesteenweg 1112
Gent,
9051
Belgium
Phone:
32 9 298 28 28
Officers
| Name | Title |
|---|---|
| Mr. Ian Crosbie | CEO & Executive Director |
| Ms. Kirsten Van Bockstaele | Chief Financial Officer |
| Ms. Lies Vanneste | Director of Investor Relations |
| Mr. Martijn Blom | Chief Commercial Officer |
| Dr. Oliver Godje M.D., Ph.D. | Chief Medical Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.1785 |
| Price-to-Sales TTM: | 69.9088 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 62 |